Search for a Universal Flu Vaccine

Published Online: Tuesday, October 16, 2012
Follow Pharmacy_Times:
In this podcast from NPR’s Science Friday, Gary Nabel, MD, PhD, director of the Vaccine Research Center at the National Institutes of Health, discusses the ongoing quest to develop a universal vaccine capable of protecting against all variants of influenza.
 
To listen, click here.
Related Articles
Key points from the Infectious Diseases Society of America’s updated guidelines for vaccination of immunocompromised individuals.
In a large-scale trial, Sanofi’s Fluzone High-Dose vaccine demonstrated efficacy in preventing influenza specifically in adults aged 65 years or older.
A National Institutes of Health–funded project aims to identify emerging drug trends to aid in public health response efforts.
Latest Issues
$auto_registration$